7 transcripts
PRPO
Earnings call transcript
NASDAQ
2022 Q2
16 Aug 22
they become productive, and of course, the costs simply don't align with our company goals. Particularly post COVID where access to customers and recovery
PRPO
Earnings call transcript
NASDAQ
2021 Q4
4 Apr 22
access to customers improved with the ability to meet with customers in-person, which significantly impact the prospecting and sales process, as well
PRPO
Earnings call transcript
NASDAQ
2021 Q3
16 Nov 21
, we're limited access to allow this kind of business or with HemeScreen where we're still able to present the concept and onboard customers. With IV-Cell
PRPO
Earnings call transcript
NASDAQ
2021 Q2
27 Aug 21
as well as inventory management, ensuring that our customers have access to quality products 365 days a year. We expect that HemeScreen will be one of our
PRPO
Earnings call transcript
NASDAQ
2020 Q4
1 Apr 21
revenues from 2019 to 2020. This has been an impressive accomplishment in a normal year and 2020 was [ph]. Our sales team stayed limited to no access
rs1
Earnings call transcript
NASDAQ
2018 Q3
19 Nov 18
of patient specimens a quarter from around the country and around the world, we gained first-hand access to the various challenges these cases present
qr5
Earnings call transcript
NASDAQ
2018 Q2
23 Aug 18
laboratory with a streamlined access to academic pathology expertise, providing a meaningful, competitive advantage that wins clients from competition
- Prev
- 1
- Next